Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma

Surgery Today

Volumn 36, Issue 11, 2006, Pages 966-974

  Kondo, Kan ^a,e   Yamasaki, Seiji ^b   Inoue, Naoya ^c   Sugie, Tomoharu ^d   Teratani, Naoki ^a   Kan, Takatsugu ^a   Shimada, Yutaka ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Murakami Memorial Hospital   (Japan)

^c JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^d Kyoto Police Hospital   (Japan)

^e Japan Baptist Hospital   (Japan)

Author keywords

Apoptosis; Cisplatin; Esophageal squamous cell carcinoma; Immunohistochemistry; TRAIL; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

CASPASE; CISPLATIN; CRYSTAL VIOLET; DEATH RECEPTOR 4; DEATH RECEPTOR 5; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURGERY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLOW CYTOMETRY; IN VIVO STUDY; MICROSCOPY; MITOCHONDRION; MOUSE; NONHUMAN; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROSPECTIVE STUDIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 33750505184     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-006-3295-5     Document Type: Article

References (35)

1. M Imamura Y Shimada Y Kanda M Fukumoto K Yanagibashi T Miyahara 1992 Usefulness of preoperative low dose cisplatin treatment for advanced esophageal cancer Surgery Today 22 409 15
2. RS Wiley K Schooley PJ Smolak WS Din C-P Huang JK Nicholl 1995 Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 673 82
3. RM Pitti SA Marsters S Ruppert CJ Donahue A Moore A Ashkenazi 1996 Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 271 22 12687 90
4. G Pan K O'Rourke AM Chinnaiyan R Gentz R Ebner J Ni 1997 The receptor for the cytotoxic ligand TRAIL Science 276 111 3
5. P Schneider JL Bodmer M Thome K Hofmann N Holler J Tschopp 1997 Characterization of two receptors for TRAIL FEBS Lett 416 329 34
6. JP Sheridan SA Marsters RM Pitti A Gurney M Skubatch D Baldwin 1997 Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 818 21
7. G Pan J Ni Yu G-L Wei Y-F R Gentz VM Dixit 1997 An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 277 815 8
8. H Walczak MA Degli-Esposti RS Johnson PJ Smolak JY Waugh N Boiani 1997 TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL EMBO J 16 17 5386 97
9. PM Chaundhary M Eby A Jasmin A Bookwalter J Murray L Hood 1997 Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kB pathway Immunity 7 821 30
10. SA Marsters JP Sheridan RM Pitti A Huang M Skubatch D Baldwin 1997 A novel receptor for Apo2L/TRAIL contains a truncated death domain Curr Biol 7 1003 6
11. G Pan J Ni Yu G L Wei Y-F VM Dixit 1998 TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling FEBS Lett 424 41 5
12. MA Degli-Esposti WC Dougall PJ Smolak JY Waugh CA Smith RG Goodwin 1997 The novel receptor TRAIL-R4 induces NF-kB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 7 813 20
13. M Jo Seol D-W Kim T-H JE Esplen K Dorko TR Billiar 2000 Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nat Med 6 5 564 7
14. K Kim MJ Fisher S-Q Xu WS El-Deiry 2000 Molecular determinants of response to TRAIL in killing of normal and cancer cells Clin Cancer Res 6 335 46
15. MM Keane SA Ettenberg MM Nau EK Russell S Lipkowitz 1999 Chemotherapy augments TRAIL-induced apoptosis in breast cell lines Cancer Res 59 734 41
16. TS Griffith CT Rauch PJ Smolak JY Waugh N Boiani DH Lynch 1999 Functional analysis of TRAIL receptors using monoclonal antibodies J Immunol 162 2597 605
17. M Leverkus M Neumann T Mengling CT Rauch E-B Brocker PH Krammer 2000 Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes Cancer Res 60 553 9
18. J-Z Qin V Chaturvedi B Bonish BJ Nickoloff 2001 Avoiding premature apoptosis of normal epidermal cells Nat Med 7 4 385 6
19. D Lawrence Z Shahrokh S Marsters K Achilles D Shih B Mounho 2001 Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions Nat Med 7 4 383 5
20. M Nagane G Pan JJ Weddle VM Dixit WK Cavenee H-J Su Huang 2000 Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo Cancer Res 60 847 53
21. A Eggert MA Grotzer TJ Zuzak BR Wiewrodt R Ho N Ikegaki 2001 Resistance to Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression Cancer Res 61 1314 9
22. T Naka K Sugamura BL Hylander MB Widmer YM Rustum EA Repasky 2002 Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice Cancer Res 62 5800 6
23. SB Gibson R Oyer AC Spalding SM Anderson GL Johnson 2000 Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL Mol Cell Biol 20 1 205 12
24. S Hopkins-Donaldson J-L Bodmer KB Bourloud CB Brognara J Tschopp 2000 Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis Cancer Res 60 4315 9
25. K Kondo S Yamasaki T Sugie N Teratani T Kan M Imamura 2006 Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma Int J Cancer 118 230 42
26. Y Shimada M Imamura T Wagata N Yamaguchi T Tobe 1992 Characterization of 21 newly established esophageal cancer cell lines Cancer 69 277 84
27. Y Kanda Y Nishiyama Y Shimada M Imamura H Nomura H Hiai 1994 Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines Int J Cancer 58 291 7
28. TS Griffith WA Chin GC Jackson DH Lynch MZ Kubin 1998 Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells J Immunol 161 2833 40
29. A Suliman A Lam R Datta RK Strivastava 2001 Intracellular mechanism of TRAIL. apoptosis through mitochondrial-dependent and -independent pathways Oncogene 20 2122 33
30. R Ravi A Bedi 2002 Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with Sulindac-mediated inhibition of Bcl-XL Cancer Res 62 1583 7
31. Kim Y-H Kim J-Y I Chang S Kim YK Pak B-H Oh 2001 Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induces apoptosis Oncogene 21 3139 48
32. M Sarker C Ruiz-Ruiz G Robledo A López-Rivas 2002 Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells Oncogene 21 4323 7
33. KG Wolter Y-T Hsu CL Smith A Nechushtan X-G Xi RJ Youle 1997 Movement of Bax from the cytosol to mitochondria during apoptosis J Cell Biol 139 5 1281 92
34. TR Singh S Shankar X Chen M Asim RK Strivastava 2003 Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related Apoptosis-inducing Ligand/Apo-2L ligand on apoptosis and on regression of breast carcinoma in vivo Cancer Res 63 5390 400
35. N Inoue S Yamasaki K Kondo T Kan K Furumoto M Imamura 2003 Dendritic cells coinjected with tumor cells treated with an anticancer drug to induce tumor rejection Surgery Today 33 269 76